STL1, a New AKT Inhibitor, Synergizes with Flavonoid Quercetin in Enhancing Cell Death in A Chronic Lymphocytic Leukemia Cell Line. The gene discussed is AKT1; the disease is B-cell chronic lymphocytic leukemia.